NCT06408051View on ClinicalTrials.gov

Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

July 31, 2023

Conditions
Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
Interventions
PROCEDURE

Injection of onabotulinumtoxinA into the bladder wall

BTX was injected into the detrusor muscles at 20 sites

Trial Locations (2)

34768

Basri Cakiroglu, Istanbul

Hisar Intercontinental Hospital, Istanbul

All Listed Sponsors
lead

Hisar Intercontinental Hospital

OTHER

NCT06408051 - Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment | Biotech Hunter | Biotech Hunter